David A. Solomon

cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics Abstract. Genome-wide DNA methylation signatures correlate with and distinguish central nervous system (CNS) tumor types. Since the publication of the init

A new open access article: cIMPACT-NOW update 9 – recommendations on genome-wide DNA methylation profiling for CNS tumor diagnostics – is now available in Neuro Oncology Advances 🔗 academic.oup.com/noa/article/... 🔓 #EANOessentials #NeuroOncology #MalignantBrainTumor

UMAP plot of the 23 methylation classes of kidney tumors we identified associated with distinct histologic features, genetic alterations, and clinical outcomes. Can now be used as the roadmap for more accurate classification of future patient tumor samples. Strong work Antonios, Omkar, and team!

Fantastic multi-institutional collaboration with GU pathology colleagues at Stanford, UCSF, NIH, & NYU developing a DNA methylation-based classifier for human kidney tumors now in press at @modernpathology.bsky.social:
www.modernpathology.org/article/S089...

Great teamwork with Craig Horbinski and colleagues highlighting the necessity of molecular testing for the accurate diagnosis & treatment of #braintumor. Still championing for insurance approval of this testing in 2025 to ensure routine patient access @braintumor.org
jamanetwork.com/journals/jam...

It's an incredible honor to be embarking on the next phase of my physician-scientist career at @stanfordbraintumor.bsky.social & @stanfordmedicine.bsky.social with generous support from the NINDS/NIH, Gilbert Family Foundation, Ben and Catherine Ivy Foundation, and Morgan Adams Foundation

It's been an incredible first year since joining this amazing group at @stanfordbraintumor.bsky.social & @stanfordnsurg.bsky.social. Looking forward to many more years of pioneering research, excellent patient care, and educating the next-gen of physician-scientists at
@stanfordmedicine.bsky.social

Dr. Nadeem Al-Adli presenting on our group's groundbreaking glioblastoma research at #SNO2024 identifying distinct patterns of epigenomic evolution of these #braintumors following therapy compared to IDH-mutant astrocytomas

Dr. Calixto-Hope Lucas presenting on our group's groundbreaking glioblastoma research at #SNO2024

Remembering fun times at #SNO2024 and looking forward to #SNO2025 in Honolulu in just a few short weeks with @neuroonc.bsky.social and colleagues from @stanfordnsurg.bsky.social & around the globe